CORC  > 中国医学科学院 北京协和医学院
Antitumor Effect of Periplocin in TRAIL-Resistant gastric cancer cells via upregulation of death receptor through activating ERK1/2-EGR1 pathway
Zhao, Lian-Mei; Li, Lei; Huang, Ying; Han, Lu-juan; Li, Dan; Huo, Bing-Jie; Dai, Su-li; Xu, Li-yan; Zhan, Qimin; Shan, Bao-En
2019
卷号58期号:6页码:1033-1045
关键词death receptors ERK1 2-EGR1 gastric cancer periplocin TRAIL
ISSN号0899-1987
DOI10.1002/mc.22991
URL标识查看原文
收录类别SCIE ; PUBMED
内容类型期刊论文
URI标识http://www.corc.org.cn/handle/1471x/6345129
专题中国医学科学院 北京协和医学院
推荐引用方式
GB/T 7714
Zhao, Lian-Mei,Li, Lei,Huang, Ying,et al. Antitumor Effect of Periplocin in TRAIL-Resistant gastric cancer cells via upregulation of death receptor through activating ERK1/2-EGR1 pathway[J],2019,58(6):1033-1045.
APA Zhao, Lian-Mei.,Li, Lei.,Huang, Ying.,Han, Lu-juan.,Li, Dan.,...&Shan, Bao-En.(2019).Antitumor Effect of Periplocin in TRAIL-Resistant gastric cancer cells via upregulation of death receptor through activating ERK1/2-EGR1 pathway.,58(6),1033-1045.
MLA Zhao, Lian-Mei,et al."Antitumor Effect of Periplocin in TRAIL-Resistant gastric cancer cells via upregulation of death receptor through activating ERK1/2-EGR1 pathway".58.6(2019):1033-1045.
个性服务
查看访问统计
相关权益政策
暂无数据
收藏/分享
所有评论 (0)
暂无评论
 

除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。


©版权所有 ©2017 CSpace - Powered by CSpace